NCT02187562View on ClinicalTrials.gov

Effect of Steady State Meloxicam on Low Dose Aspirin Induced Inhibition of Platelet Aggregation and Thromboxane Synthesis in Healthy Males and Females

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

August 31, 2002

Conditions
Healthy
Interventions
DRUG

Meloxicam

DRUG

Aspirin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY